Publication


Featured researches published by Leonard S. Rosenberg.


Drug Development and Industrial Pharmacy | 1989

Application of a Second-Order Derivtive Spectroscopic Technique: Determination of the Ionization Constants of Phenytoin and Phenobarbital

Leonard S. Rosenberg; Jenny L. Jackson

AbstractAbsorption spectroscopy can be used to determine the pK of a compound when a change in the spectral pattern can be related to a change in the protonation state of an ionizable group. The calculation of a pK becomes difficult (standard error increases) when these spectral changes are indistinct or are minimally resolved. In these cases, the ability of higher-order derivative spectroscopy to enhance the short-range fine structure of a spectra usually offers adequate spectral resolution for quantitative pK determinations.


Pharmaceutical Research | 1988

An accurate prediction of the ph change due to degradation correction for a produced secondary buffering system

Leonard S. Rosenberg; Cheryl K. Hostetler; Dietmar M. Wagenknecht; Diane A. Aunet

Esmolol hydrochloride degrades in aqueous solutions by the hydrolysis of a labile aliphatic carboxy-ester group. The products are methanol and ASL-8123. The resulting aliphatic carboxylic acid moiety (ASL-8123) has a pK of 4.80, which is within 1 pH unit of the pH of the formulation. ASL-8123 therefore acts as a “secondary buffer” and minimizes the change in pH due to degradation. Equations are presented to calculate the change in the pH when the primary degradation product acts as a secondary buffer. This information can be used in the development of a parenteral product to predict, a priori, the concentration of buffer necessary for optimal pH maintenance. This knowledge can reduce the number of formulation screens required to determine the necessary buffer capacity for optimal drug stability.


Archive | 1990

Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester

Dale E. Herbranson; Earl R. Speicher; Leonard S. Rosenberg


Archive | 1989

Stable pharmaceutical composition

Leonard S. Rosenberg; Cheryl K. Black; Earl R. Speicher; Dietmar M. Wagenknecht


Archive | 1990

Stabile Arzneimittel mit 3-(hydroxymethyl)-5,5-diphenylhydantoin-dinatrium-phosphatester. The stable pharmaceutical with 3- (hydroxymethyl) -5,5-diphenylhydantoin disodium phosphate ester.

Dale E. Herbranson; Earl R. Speicher; Leonard S. Rosenberg


Archive | 1990

Composition pharmaceutique stable d'ester de phosphate de disodium de 3-(hydroxymethyl)-5,5-diphenylhydantoïne

Dale E. Herbranson; Leonard S. Rosenberg; Earl R. Speicher


Archive | 1990

Stable drugs with 3- (hydroxymethyl) -5,5-diphenylhydantoin disodium phosphatester.

Dale E. Herbranson; Earl R. Speicher; Leonard S. Rosenberg


Archive | 1989

Stable pharmaceutical composition containing esmolol

Earl R. Speicher; Cheryl K. Black; Dietmar M. Wagenknecht; Leonard S. Rosenberg


Archive | 1989

Stabile pharmazeutische zusammensetzung. The stable pharmaceutical composition.

Leonard S. Rosenberg; Cheryl K. Black; Earl R. Speicher; Dietmar M. Wagenknecht


Archive | 1989

Stabile pharmazeutische zusammensetzung

Leonard S. Rosenberg; Cheryl K. Black; Earl R. Speicher; Dietmar M. Wagenknecht

Researchain Logo
Decentralizing Knowledge